Swine Flu Vaccination Market Key Drivers, Trends, Growth, Outlook 2024-2033

Overview and Scope

Swine flu vaccination refers to vaccines designed to protect against the influenza viruses that commonly infect pigs (swine flu). The purpose of vaccines is to prevent transmission of swine flu from pigs to humans.

Sizing and Forecast

The swine flu vaccination market size has grown strongly in recent years. It will grow from $13.01 billion in 2023 to $13.99 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the increasing prevalence of flu, declining immunity among the geriatric population, increasing incidence of swine flu cases, government initiatives towards immunization programs, and advancements in vaccine production and distribution.

The swine flu vaccination market size is expected to see strong growth in the next few years. It will grow to $18.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing demand for intramuscular vaccines, increasing awareness of new technologies in vaccination, increasing rate of elderly population, the need for vaccinations to protect the public’s health, increased incidence of disease and episodes of pandemic worldwide from h1n1 infection. Major trends in the forecast period include technological advancement, business expansions, product launches, strategic mergers and acquisitions, and partnerships among pharmaceutical firms.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Segmentation & Regional Insights

The swine flu vaccination market covered in this report is segmented –

1) By Vaccine Type: Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type

2) By Treatment Type: Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella

3) By End User: Hospital, Clinic, Other End User

North America was the largest region in the Swine Flu Vaccination market in 2023. The regions covered in the swine flu vaccination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15678&type=smp

Major Driver Impacting Market Growth

The government initiatives toward vaccination programs are expected to propel the growth of the swine flu vaccination market going forward. Government initiatives toward vaccination programs refer to policies and actions undertaken by governments to promote and facilitate vaccination campaigns. The swine flu vaccination incentivizes governments to prioritize immunization programs by providing necessary vaccines and resources to combat outbreaks effectively, bolstering public health initiatives. For instance, in October 2021, according to reports published by the Centers for Disease Control and Prevention, a US-based national public health agency responsible for controlling the introduction and spread of infectious diseases, Flu vaccination rates increased significantly in the 2020–2021 season, with 50%–55% of adults receiving a vaccination, compared to 48% in the previous year. Also, the government has allocated 9.3 million doses of adult influenza vaccine to establish a stockpile in case of supply issues. Therefore, the increasing government initiatives toward vaccination programs are driving the growth of the swine flu vaccination market.

Key Industry Players

Major companies operating in the swine flu vaccination market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Mylan N.V., Moderna Inc., Baxter International Inc., Zoetis Inc., Elanco Animal Health, Cipla Inc., Lupin Ltd., Virbac S.A, Sinovac Biotech Ltd., Serum Institute of India Private Limited., Vetoquinol S.A, IDT Biologika GmbH, Bharat Biotech International Limited, Medicago Inc., Panacea Biotec, Hipra

The swine flu vaccination market report table of contents includes: